{"id":17703,"date":"2026-09-23T09:14:59","date_gmt":"2026-09-23T07:14:59","guid":{"rendered":"https:\/\/www.interpharma.ch\/?p=17703"},"modified":"2026-09-18T15:38:36","modified_gmt":"2026-09-18T13:38:36","slug":"communique-de-presse-la-population-souhaite-un-meilleur-acces-aux-medicaments-innovants","status":"publish","type":"post","link":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-la-population-souhaite-un-meilleur-acces-aux-medicaments-innovants\/","title":{"rendered":"Communiqu\u00e9 de presse: La population souhaite un meilleur acc\u00e8s aux m\u00e9dicaments innovants"},"content":{"rendered":"\n<p><strong>Deux \u00e9tudes actuelles montrent que la population suisse continue d\u2019attribuer une bonne appr\u00e9ciation au syst\u00e8me de sant\u00e9. En m\u00eame temps, elle souhaite un acc\u00e8s large et rapide aux nouveaux m\u00e9dicaments innovants. Les Suisses-ses sont pr\u00eat-e-s dans ce but \u00e0 payer 33 francs suppl\u00e9mentaires par mois pour la prime de leur caisse-maladie.<\/strong><\/p>\n\n\n\n<p>Comme le montre le Moniteur de la sant\u00e9 2026 d\u2019Interpharma, la population suisse continue d\u2019avoir une opinion tr\u00e8s positive de la qualit\u00e9 du syst\u00e8me de sant\u00e9: 79% pensent qu\u2019elle est bonne ou tr\u00e8s bonne. En m\u00eame temps, les opinions sont claires sur ce qui caract\u00e9rise une bonne prise en charge sanitaire: en font partie une bonne formation du personnel m\u00e9dical et un acc\u00e8s facile aux m\u00e9decins de famille et aux sp\u00e9cialistes dans sa propre r\u00e9gion, mais aussi un acc\u00e8s \u00e9quitable aux nouveaux m\u00e9dicaments et traitements innovants. C\u2019est ce que souligne aussi une nouvelle \u00e9tude de Swiss Economics: pour disposer d\u2019autant de m\u00e9dicaments que les Allemand-e-s, les Suisses-ses seraient pr\u00eat-e-s \u00e0 payer environ 33 francs suppl\u00e9mentaires par mois pour la prime de leur caisse-maladie. Actuellement, environ la moiti\u00e9 seulement des m\u00e9dicaments innovants disponibles en Allemagne sont \u00e9galement pris en charge par les caisses-maladie en Suisse (IQVIA, 2026).<\/p>\n\n\n\n<p><strong>Importance de l\u2019industrie pharmaceutique<\/strong><\/p>\n\n\n\n<p>Le Moniteur de la sant\u00e9 montre aussi que le r\u00f4le de l\u2019industrie pharmaceutique pratiquant la recherche est largement reconnu dans la population: 90% sont d\u2019avis qu\u2019il faut que la recherche, le d\u00e9veloppement et la production de m\u00e9dicaments restent fortement ancr\u00e9s en Suisse. De plus, 69% pensent que si la Suisse s\u2019affaiblit en tant que place pharmaceutique, cela peut aussi, \u00e0 long terme, mettre en p\u00e9ril les soins de sant\u00e9 dans le pays.<\/p>\n\n\n\n<p>\u00abLes r\u00e9sultats montrent que la population attache une grande importance \u00e0 l\u2019acc\u00e8s aux m\u00e9dicaments innovants. Une politique de sant\u00e9 moderne doit donc consid\u00e9rer l\u2019innovation, non seulement sous l\u2019angle des co\u00fbts, mais aussi en tenant compte de la qualit\u00e9 de la prise en charge. Or, l\u2019\u00e9volution actuelle en Suisse ne va pas dans la direction d\u2019un meilleur acc\u00e8s aux m\u00e9dicaments innovants, mais au contraire d\u2019un acc\u00e8s de plus en plus limit\u00e9\u00bb, constate Ren\u00e9 Buholzer, directeur d\u2019Interpharma.<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td>Le Moniteur de la sant\u00e9 2026 a \u00e9t\u00e9 mandat\u00e9 par Interpharma pour la 25e fois cons\u00e9cutive et r\u00e9alis\u00e9 par gfs.bern. Il se base sur une enqu\u00eate repr\u00e9sentative r\u00e9alis\u00e9e en Suisse aupr\u00e8s de 1046 personnes entre le 28 juillet et le 17 ao\u00fbt 2026. L\u2019\u00e9tude sur la disposition \u00e0 payer a \u00e9t\u00e9 r\u00e9alis\u00e9e par Swiss Economics sur mandat d\u2019Interpharma et se base sur une enqu\u00eate quantitative aupr\u00e8s de 1318 personnes en juillet 2026.<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Deux \u00e9tudes actuelles montrent que la population suisse continue d\u2019attribuer une bonne appr\u00e9ciation au syst\u00e8me de sant\u00e9. En m\u00eame temps, elle souhaite un acc\u00e8s large et rapide aux nouveaux m\u00e9dicaments innovants. Les Suisses-ses sont pr\u00eat-e-s dans ce but \u00e0 payer 33 francs suppl\u00e9mentaires par mois pour la prime de leur caisse-maladie. Comme le montre le [&hellip;]<\/p>\n","protected":false},"author":7,"featured_media":17702,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"tags":[122,127,148],"class_list":["post-17703","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","tag-communique-de-presse","tag-acces-des-patients","tag-place-pharmaceutique-suisse"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.9 (Yoast SEO v27.9) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Communiqu\u00e9 de presse: La population souhaite un meilleur acc\u00e8s aux m\u00e9dicaments innovants - Interpharma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.interpharma.ch\/blog\/medienmitteilung-die-bevoelkerung-erwartet-einen-besseren-zugang-zu-innovativen-medikamenten\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Communiqu\u00e9 de presse: La population souhaite un meilleur acc\u00e8s aux m\u00e9dicaments innovants\" \/>\n<meta property=\"og:description\" content=\"Deux \u00e9tudes actuelles montrent que la population suisse continue d\u2019attribuer une bonne appr\u00e9ciation au syst\u00e8me de sant\u00e9. En m\u00eame temps, elle souhaite un acc\u00e8s large et rapide aux nouveaux m\u00e9dicaments innovants. Les Suisses-ses sont pr\u00eat-e-s dans ce but \u00e0 payer 33 francs suppl\u00e9mentaires par mois pour la prime de leur caisse-maladie. Comme le montre le [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.interpharma.ch\/blog\/medienmitteilung-die-bevoelkerung-erwartet-einen-besseren-zugang-zu-innovativen-medikamenten\/\" \/>\n<meta property=\"og:site_name\" content=\"Interpharma\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-23T07:14:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/09\/ybn_interpharma_114_low-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1920\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"lukaskuemmerli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@interpharma_ch\" \/>\n<meta name=\"twitter:site\" content=\"@interpharma_ch\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"lukaskuemmerli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/blog\\\/medienmitteilung-die-bevoelkerung-erwartet-einen-besseren-zugang-zu-innovativen-medikamenten\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/blog\\\/medienmitteilung-die-bevoelkerung-erwartet-einen-besseren-zugang-zu-innovativen-medikamenten\\\/\"},\"author\":{\"name\":\"lukaskuemmerli\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#\\\/schema\\\/person\\\/2854d813965ba4a7feaeffbe96f8eadf\"},\"headline\":\"Communiqu\u00e9 de presse: La population souhaite un meilleur acc\u00e8s aux m\u00e9dicaments innovants\",\"datePublished\":\"2026-09-23T07:14:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/blog\\\/medienmitteilung-die-bevoelkerung-erwartet-einen-besseren-zugang-zu-innovativen-medikamenten\\\/\"},\"wordCount\":484,\"publisher\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/blog\\\/medienmitteilung-die-bevoelkerung-erwartet-einen-besseren-zugang-zu-innovativen-medikamenten\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.interpharma.ch\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/ybn_interpharma_114_low-scaled.jpg\",\"keywords\":[\"Communiqu\u00e9 de presse\",\"Acc\u00e8s des patients\",\"place pharmaceutique suisse\"],\"inLanguage\":\"fr-FR\",\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/blog\\\/medienmitteilung-die-bevoelkerung-erwartet-einen-besseren-zugang-zu-innovativen-medikamenten\\\/\",\"url\":\"https:\\\/\\\/www.interpharma.ch\\\/blog\\\/medienmitteilung-die-bevoelkerung-erwartet-einen-besseren-zugang-zu-innovativen-medikamenten\\\/\",\"name\":\"Communiqu\u00e9 de presse: La population souhaite un meilleur acc\u00e8s aux m\u00e9dicaments innovants - Interpharma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/blog\\\/medienmitteilung-die-bevoelkerung-erwartet-einen-besseren-zugang-zu-innovativen-medikamenten\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/blog\\\/medienmitteilung-die-bevoelkerung-erwartet-einen-besseren-zugang-zu-innovativen-medikamenten\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.interpharma.ch\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/ybn_interpharma_114_low-scaled.jpg\",\"datePublished\":\"2026-09-23T07:14:59+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/blog\\\/medienmitteilung-die-bevoelkerung-erwartet-einen-besseren-zugang-zu-innovativen-medikamenten\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.interpharma.ch\\\/blog\\\/medienmitteilung-die-bevoelkerung-erwartet-einen-besseren-zugang-zu-innovativen-medikamenten\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/blog\\\/medienmitteilung-die-bevoelkerung-erwartet-einen-besseren-zugang-zu-innovativen-medikamenten\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.interpharma.ch\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/ybn_interpharma_114_low-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/www.interpharma.ch\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/ybn_interpharma_114_low-scaled.jpg\",\"width\":2560,\"height\":1920,\"caption\":\"Symbolbild Gesundheit\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/blog\\\/medienmitteilung-die-bevoelkerung-erwartet-einen-besseren-zugang-zu-innovativen-medikamenten\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Communiqu\u00e9 de presse: La population souhaite un meilleur acc\u00e8s aux m\u00e9dicaments innovants\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#website\",\"url\":\"https:\\\/\\\/www.interpharma.ch\\\/\",\"name\":\"Interpharma\",\"description\":\"Verband der forschenden Pharmazeutischen Firmen\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.interpharma.ch\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#organization\",\"name\":\"Interpharma\",\"url\":\"https:\\\/\\\/www.interpharma.ch\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.interpharma.ch\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg\",\"contentUrl\":\"https:\\\/\\\/www.interpharma.ch\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg\",\"width\":\"1200\",\"height\":\"1200\",\"caption\":\"Interpharma\"},\"image\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/interpharma_ch\",\"https:\\\/\\\/ch.linkedin.com\\\/company\\\/interpharma\",\"https:\\\/\\\/www.instagram.com\\\/interpharma_ch\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#\\\/schema\\\/person\\\/2854d813965ba4a7feaeffbe96f8eadf\",\"name\":\"lukaskuemmerli\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c3bfeac2b6c479264ad184573779a451a81113f9e7cbabe607006461ca783d10?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c3bfeac2b6c479264ad184573779a451a81113f9e7cbabe607006461ca783d10?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c3bfeac2b6c479264ad184573779a451a81113f9e7cbabe607006461ca783d10?s=96&d=mm&r=g\",\"caption\":\"lukaskuemmerli\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Communiqu\u00e9 de presse: La population souhaite un meilleur acc\u00e8s aux m\u00e9dicaments innovants - Interpharma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.interpharma.ch\/blog\/medienmitteilung-die-bevoelkerung-erwartet-einen-besseren-zugang-zu-innovativen-medikamenten\/","og_locale":"fr_FR","og_type":"article","og_title":"Communiqu\u00e9 de presse: La population souhaite un meilleur acc\u00e8s aux m\u00e9dicaments innovants","og_description":"Deux \u00e9tudes actuelles montrent que la population suisse continue d\u2019attribuer une bonne appr\u00e9ciation au syst\u00e8me de sant\u00e9. En m\u00eame temps, elle souhaite un acc\u00e8s large et rapide aux nouveaux m\u00e9dicaments innovants. Les Suisses-ses sont pr\u00eat-e-s dans ce but \u00e0 payer 33 francs suppl\u00e9mentaires par mois pour la prime de leur caisse-maladie. Comme le montre le [&hellip;]","og_url":"https:\/\/www.interpharma.ch\/blog\/medienmitteilung-die-bevoelkerung-erwartet-einen-besseren-zugang-zu-innovativen-medikamenten\/","og_site_name":"Interpharma","article_published_time":"2026-09-23T07:14:59+00:00","og_image":[{"width":2560,"height":1920,"url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/09\/ybn_interpharma_114_low-scaled.jpg","type":"image\/jpeg"}],"author":"lukaskuemmerli","twitter_card":"summary_large_image","twitter_creator":"@interpharma_ch","twitter_site":"@interpharma_ch","twitter_misc":{"\u00c9crit par":"lukaskuemmerli","Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.interpharma.ch\/blog\/medienmitteilung-die-bevoelkerung-erwartet-einen-besseren-zugang-zu-innovativen-medikamenten\/#article","isPartOf":{"@id":"https:\/\/www.interpharma.ch\/blog\/medienmitteilung-die-bevoelkerung-erwartet-einen-besseren-zugang-zu-innovativen-medikamenten\/"},"author":{"name":"lukaskuemmerli","@id":"https:\/\/www.interpharma.ch\/#\/schema\/person\/2854d813965ba4a7feaeffbe96f8eadf"},"headline":"Communiqu\u00e9 de presse: La population souhaite un meilleur acc\u00e8s aux m\u00e9dicaments innovants","datePublished":"2026-09-23T07:14:59+00:00","mainEntityOfPage":{"@id":"https:\/\/www.interpharma.ch\/blog\/medienmitteilung-die-bevoelkerung-erwartet-einen-besseren-zugang-zu-innovativen-medikamenten\/"},"wordCount":484,"publisher":{"@id":"https:\/\/www.interpharma.ch\/#organization"},"image":{"@id":"https:\/\/www.interpharma.ch\/blog\/medienmitteilung-die-bevoelkerung-erwartet-einen-besseren-zugang-zu-innovativen-medikamenten\/#primaryimage"},"thumbnailUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/09\/ybn_interpharma_114_low-scaled.jpg","keywords":["Communiqu\u00e9 de presse","Acc\u00e8s des patients","place pharmaceutique suisse"],"inLanguage":"fr-FR","copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/www.interpharma.ch\/#organization"}},{"@type":"WebPage","@id":"https:\/\/www.interpharma.ch\/blog\/medienmitteilung-die-bevoelkerung-erwartet-einen-besseren-zugang-zu-innovativen-medikamenten\/","url":"https:\/\/www.interpharma.ch\/blog\/medienmitteilung-die-bevoelkerung-erwartet-einen-besseren-zugang-zu-innovativen-medikamenten\/","name":"Communiqu\u00e9 de presse: La population souhaite un meilleur acc\u00e8s aux m\u00e9dicaments innovants - Interpharma","isPartOf":{"@id":"https:\/\/www.interpharma.ch\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.interpharma.ch\/blog\/medienmitteilung-die-bevoelkerung-erwartet-einen-besseren-zugang-zu-innovativen-medikamenten\/#primaryimage"},"image":{"@id":"https:\/\/www.interpharma.ch\/blog\/medienmitteilung-die-bevoelkerung-erwartet-einen-besseren-zugang-zu-innovativen-medikamenten\/#primaryimage"},"thumbnailUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/09\/ybn_interpharma_114_low-scaled.jpg","datePublished":"2026-09-23T07:14:59+00:00","breadcrumb":{"@id":"https:\/\/www.interpharma.ch\/blog\/medienmitteilung-die-bevoelkerung-erwartet-einen-besseren-zugang-zu-innovativen-medikamenten\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.interpharma.ch\/blog\/medienmitteilung-die-bevoelkerung-erwartet-einen-besseren-zugang-zu-innovativen-medikamenten\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.interpharma.ch\/blog\/medienmitteilung-die-bevoelkerung-erwartet-einen-besseren-zugang-zu-innovativen-medikamenten\/#primaryimage","url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/09\/ybn_interpharma_114_low-scaled.jpg","contentUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/09\/ybn_interpharma_114_low-scaled.jpg","width":2560,"height":1920,"caption":"Symbolbild Gesundheit"},{"@type":"BreadcrumbList","@id":"https:\/\/www.interpharma.ch\/blog\/medienmitteilung-die-bevoelkerung-erwartet-einen-besseren-zugang-zu-innovativen-medikamenten\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.interpharma.ch\/fr\/"},{"@type":"ListItem","position":2,"name":"Communiqu\u00e9 de presse: La population souhaite un meilleur acc\u00e8s aux m\u00e9dicaments innovants"}]},{"@type":"WebSite","@id":"https:\/\/www.interpharma.ch\/#website","url":"https:\/\/www.interpharma.ch\/","name":"Interpharma","description":"Verband der forschenden Pharmazeutischen Firmen","publisher":{"@id":"https:\/\/www.interpharma.ch\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.interpharma.ch\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.interpharma.ch\/#organization","name":"Interpharma","url":"https:\/\/www.interpharma.ch\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/","url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg","contentUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg","width":"1200","height":"1200","caption":"Interpharma"},"image":{"@id":"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/interpharma_ch","https:\/\/ch.linkedin.com\/company\/interpharma","https:\/\/www.instagram.com\/interpharma_ch\/"]},{"@type":"Person","@id":"https:\/\/www.interpharma.ch\/#\/schema\/person\/2854d813965ba4a7feaeffbe96f8eadf","name":"lukaskuemmerli","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/c3bfeac2b6c479264ad184573779a451a81113f9e7cbabe607006461ca783d10?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/c3bfeac2b6c479264ad184573779a451a81113f9e7cbabe607006461ca783d10?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c3bfeac2b6c479264ad184573779a451a81113f9e7cbabe607006461ca783d10?s=96&d=mm&r=g","caption":"lukaskuemmerli"}}]}},"_links":{"self":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts\/17703","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/comments?post=17703"}],"version-history":[{"count":2,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts\/17703\/revisions"}],"predecessor-version":[{"id":17706,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts\/17703\/revisions\/17706"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/media\/17702"}],"wp:attachment":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/media?parent=17703"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/tags?post=17703"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}